JPH0237326B2 - - Google Patents

Info

Publication number
JPH0237326B2
JPH0237326B2 JP57063194A JP6319482A JPH0237326B2 JP H0237326 B2 JPH0237326 B2 JP H0237326B2 JP 57063194 A JP57063194 A JP 57063194A JP 6319482 A JP6319482 A JP 6319482A JP H0237326 B2 JPH0237326 B2 JP H0237326B2
Authority
JP
Japan
Prior art keywords
diuretic
thiazide
pharmacological
hypertension
salt
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
JP57063194A
Other languages
English (en)
Japanese (ja)
Other versions
JPS57197219A (en
Inventor
Arigorii Maruteri Edoarudo
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Leo Pharma AS
Original Assignee
Leo Pharmaceutical Products Ltd AS
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Leo Pharmaceutical Products Ltd AS filed Critical Leo Pharmaceutical Products Ltd AS
Publication of JPS57197219A publication Critical patent/JPS57197219A/ja
Publication of JPH0237326B2 publication Critical patent/JPH0237326B2/ja
Granted legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/54—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/63—Compounds containing para-N-benzenesulfonyl-N-groups, e.g. sulfanilamide, p-nitrobenzenesulfonyl hydrazide
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/63—Compounds containing para-N-benzenesulfonyl-N-groups, e.g. sulfanilamide, p-nitrobenzenesulfonyl hydrazide
    • A61K31/635—Compounds containing para-N-benzenesulfonyl-N-groups, e.g. sulfanilamide, p-nitrobenzenesulfonyl hydrazide having a heterocyclic ring, e.g. sulfadiazine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/08—Vasodilators for multiple indications
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives

Landscapes

  • Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Pyridine Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
JP57063194A 1981-04-15 1982-04-14 Pharmacological medicine and manufacture Granted JPS57197219A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB8111986 1981-04-15

Publications (2)

Publication Number Publication Date
JPS57197219A JPS57197219A (en) 1982-12-03
JPH0237326B2 true JPH0237326B2 (enExample) 1990-08-23

Family

ID=10521198

Family Applications (1)

Application Number Title Priority Date Filing Date
JP57063194A Granted JPS57197219A (en) 1981-04-15 1982-04-14 Pharmacological medicine and manufacture

Country Status (15)

Country Link
US (1) US4409222A (enExample)
JP (1) JPS57197219A (enExample)
AU (1) AU550569B2 (enExample)
BE (1) BE892873A (enExample)
CA (1) CA1172566A (enExample)
DE (1) DE3213579A1 (enExample)
FR (1) FR2504008B1 (enExample)
GB (1) GB2098864B (enExample)
IE (1) IE52935B1 (enExample)
IT (1) IT1152106B (enExample)
NL (1) NL8201493A (enExample)
NZ (1) NZ200185A (enExample)
PH (1) PH21623A (enExample)
SE (1) SE461703B (enExample)
ZA (1) ZA822120B (enExample)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS604120A (ja) * 1983-06-22 1985-01-10 Shionogi & Co Ltd 作用持続型ピナシジル製剤
US4617311A (en) * 1985-05-17 1986-10-14 Eli Lilly And Company Antiasthmatic method
WO2015117024A1 (en) 2014-01-31 2015-08-06 Mayo Foundation For Medical Education And Research Novel therapeutics for the treatment of glaucoma
AU2020403144A1 (en) 2019-12-12 2022-07-14 Mayo Foundation For Medical Education And Research Controlled-delivery cromakalim prodrugs
KR20250096644A (ko) 2022-11-04 2025-06-27 클라리스 바이오, 인크. 크로마칼림의 국소 안구 전달

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1489879A (en) * 1974-12-20 1977-10-26 Leo Pharm Prod Ltd N'-cyano-n'-3-pyridylguanidines

Also Published As

Publication number Publication date
IT8220717A0 (it) 1982-04-14
IE820676L (en) 1982-10-15
NZ200185A (en) 1986-09-10
IT1152106B (it) 1986-12-31
PH21623A (en) 1987-12-11
FR2504008A1 (fr) 1982-10-22
JPS57197219A (en) 1982-12-03
AU550569B2 (en) 1986-03-27
GB2098864A (en) 1982-12-01
SE461703B (sv) 1990-03-19
BE892873A (fr) 1982-10-15
IE52935B1 (en) 1988-04-13
US4409222A (en) 1983-10-11
FR2504008B1 (fr) 1986-09-19
DE3213579C2 (enExample) 1992-04-30
SE8202351L (sv) 1982-10-16
NL8201493A (nl) 1982-11-01
CA1172566A (en) 1984-08-14
DE3213579A1 (de) 1982-11-04
AU8262282A (en) 1983-05-12
ZA822120B (en) 1983-03-30
GB2098864B (en) 1984-12-12

Similar Documents

Publication Publication Date Title
KR0148589B1 (ko) 항종양 효과의 상승 및 종양의 치료를 위한 조성물 및 키트
HUT72313A (en) Pharmaceutical compositions for treating menstrual symptoms and process for their preparation
PL200957B1 (pl) Kompozycja farmaceutyczna celecoxib'u i zastosowanie kompozycji farmaceutycznej
WO1993001812A1 (en) S-(3-(4(5))-imidazolyl)propyl)isothiourea as selective trhistomine h3 receptor antagonist
JPH01313427A (ja) ジヒドロピリジン類を含有する徐放性製剤
ES2269071T3 (es) Composiciones de lasofoxileno.
JPH0237326B2 (enExample)
EP0005015B1 (en) Use of a xanthine derivate in the manufacture of a medicament
US4952410A (en) Pharmaceutical products of moxonidine and hydrochlorothiazide
CN1859913A (zh) 改善肾功能损伤个体多尿症的方法
AU666992B2 (en) Pharmaceutical composition for preventing or treating arteriosclerosis
US4794111A (en) Dihydropyridine preparations containing β-blockers
US4088778A (en) Method for the treatment of hypertension
US4225607A (en) Pharmaceutical composition containing a xanthine derivative
US4298611A (en) Process for reducing blood pressure in animals
US3574852A (en) Treating depression with the n-oxide of n-(3' - dimethylamino propyl)-iminodibenzyl
EP2146713B1 (fr) Utilisation du 4-cyclopropylmethoxy-n-(3,5-dichloro-1-oxydo-4- pyridin-4-yl)-5-(methoxy)pyridine-2-carboxamide pour le traitement des traumatismes craniens
WO2002087335A1 (en) Method for treating tumors by the administration of tegafur, uracil, folinic acid, and cyclophosphamide
US3857944A (en) 1-piperazinoisoquinolines as inotropic agents
US3457350A (en) Method of treating asthma
JPH0873352A (ja) 高血圧治療剤
US4178374A (en) Novel pharmaceutical compositions of β-blockers with diuretics
US5182285A (en) Cell-protective composition for preventing or treating of peptic ulcer
IE43955B1 (en) Pharmaceutical composition and dosage units thereof
US4238485A (en) Novel pharmaceutical compositions